Hire an Advanced Robo-Advisor to Trade VRTX on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Smart Auto-Trading?
Smart Auto-Trading is an advanced Robo-Trader designed to automate systematic stock investing. Its robo is designed to screens, monitors and auto-trades elite stocks like VERTEX PHARMACEUTICALS INCORPORATED (VRTX) using Artificial Intelligence signals. It is designed to augment your profit potential.
Smart Auto-Trading produces short-term trades which makes it an ideal tool for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMAs. If also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.
Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest. Ally Invest is one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $25,000 in your account and connect Smart Auto-Trading to auto-trade.
There are clear benefits associated with using a robo-Trader such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades the S&P 500 on your behalf. Its Artificial Intelligence is on the lookout, working to maximize your potential every business day of the year. It 'trades on the news' taking advantage of price changes and trends by listening to trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-Trader to take advantage of Government grade listening technology, Artificial Intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Traders like other investment methods rely on favorable market conditions to provide positive outcomes.
VERTEX PHARMACEUTICALS INCORPORATED (VRTX) News
Caxton Associates LP Invests $304,000 in Vertex Pharmaceuticals Incorporated (VRTX) Stock
December 24, 2017
Caxton Associates LP bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,000 shares of the pharmaceutical company’s stock, valued at approximately $304,000.
Several other hedge funds have also added to or reduced their stakes in VRTX. BlackRock Inc. grew its position in shares of Vertex Pharmaceuticals by 0.8% during the 2nd quarter. BlackRock Inc. now owns 19,405,981 shares of the pharmaceutical company’s stock valued at $2,500,849,000 after acquiring an additional 159,601 shares during the period. Vanguard Group Inc. boosted its holdings in Vertex Pharmaceuticals by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 16,979,872 shares of the pharmaceutical company’s stock worth $2,188,196,000 after buying an additional 504,982 shares during the period. Jennison Associates LLC boosted its holdings in Vertex Pharmaceuticals by 19.0% in the 3rd quarter. Jennison Associates LLC now owns 6,017,766 shares of the pharmaceutical company’s stock worth $914,941,000 after buying an additional 962,644 shares during the period. TIAA CREF Investment Management LLC boosted its holdings in Vertex Pharmaceuticals by 28.1% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 2,077,303 shares of the pharmaceutical company’s stock worth $267,702,000 after buying an additional 456,290 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in Vertex Pharmaceuticals by 0.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,994,410 shares of the pharmaceutical company’s stock worth $303,230,000 after buying an additional 12,454 shares during the period. Hedge funds and other institutional investors own 93.09% of the company’s stock.Get Started today! - Risk Free